Regeneron says antibody cocktail reduces risk of contracting Covid by 80% for at least 8 MONTHS  

    [ad_1]

    BREAKING NEWS: Regeneron says its antibody cocktail reduces the risk of contracting Covid by more than 80% for at least EIGHT MONTHS

    • Regeneron say its antibody cocktail REGEN-COV reduces the risk of contracting COVID-19 by 81.6% two to eight months after it is administered 
    • The drug was authorized last year as a treatment for the virus but has since been expanded so it can be used as a prophylactic  


    Regeneron Pharmaceuticals Inc announced on Monday that its antibody cocktail can severely slash the risk of being infected with COVID-19 for up to eight months. 

    The combo therapy, REGEN-COV, was approved in November 2020 for emergency use to treat people with mild-to-moderate COVID-19 cases in the U.S.

    But the U.S. Food and Drug Administration (FDA) expanded authorization in July 2021 so the drug can also be used as a preventive treatment.

    Late-stage trial data showed a single dose can lower the risk of contracting Covid by 81.6 percent between two and six-months after the cocktail is administered. 

    Regeneron say its antibody cocktail REGEN-COV (above) reduces the risk of contracting COVID-19 by 81.6% two to eight months after it is administered

    Regeneron say its antibody cocktail REGEN-COV (above) reduces the risk of contracting COVID-19 by 81.6% two to eight months after it is administered 

    This is a breaking news story and will be updated.

    Advertisement

    [ad_2]

    Previous articleLarry Emdur asks fans for advice on investment property
    Next articleJade Thirlwall reflects on experiencing racism, tragedy, anorexia and body image woes

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here